Today: 19 November 2025
Subscribe
Browse Category

Healthcare Technology News 3 July 2025 - 22 October 2025

VSee Health (VSEE) Stock Skyrockets 75% on $10M Hospital Teleradiology Contract

VSee Health (VSEE) Stock Skyrockets 75% on $10M Hospital Teleradiology Contract

Teleradiology Contract Ignites Stock Rally On Oct. 21 VSee Health (NASDAQ: VSEE) stunned the market by announcing a landmark teleradiology services agreement with a major Level-1 trauma hospital system. The multi-year deal – which began service in June – is valued at roughly $10 million over two years, with additional $5+ million in potential bonuses for meeting volume targets streetinsider.com financialcontent.com. Management says it will double the company’s annual recurring revenue, a milestone that co-CEO Dr. Imo Aisiku hailed as “just the beginning.” In a press statement he called the deal “a game-changer for VSee Health and our shareholders,” saying
22 October 2025
 ·  ·  ·  · 
VSee Health (VSEE) Stock Rockets 75% on $10M Hospital Teleradiology Deal – Is This Telehealth’s Next Big Winner?

VSee Health (VSEE) Stock Rockets 75% on $10M Hospital Teleradiology Deal – Is This Telehealth’s Next Big Winner?

VSee’s Game-Changing Teleradiology Deal On Oct. 21, 2025 VSee Health (NASDAQ: VSEE) announced a “landmark” multi-year teleradiology contract with a major Level 1 trauma hospital system finviz.com. Under the deal (executed May 7, 2025, services since June), VSee will provide 24/7 remote radiology interpretations across a network of hospitals. The company projects $10 million in gross revenue over two years from this contract, with potential to add $5+ million in bonuses or expansions finviz.com. Management says this “blockbuster contract” will double annual recurring revenue and unlock new opportunities in telehealth finviz.com streetinsider.com. Co-CEO Dr. Imo Aisiku enthused: “Doubling our annual recurring
21 October 2025
 ·  ·  ·  · 
Strata Skin Sciences (SSKN) Stock Surges on Laser-Therapy Breakthrough – Buy, Hold or Sell?

Strata Skin Sciences (SSKN) Stock Surges on Laser-Therapy Breakthrough – Buy, Hold or Sell?

Strata’s XTRAC® excimer laser (pictured above) is a targeted UVB therapy device used to treat localized skin conditions like psoriasis, vitiligo, and eczema biospace.com globenewswire.com. By customizing UV dose to each patient’s lesion, XTRAC spares healthy skin and enables precision treatment (often via a fee-per-treatment partnership model rather than equipment sales) globenewswire.com biospace.com. Company Background STRATA Skin Sciences, Inc. is a medical tech company specializing in dermatologic treatments. Its core product is the XTRAC® 308nm Excimer Laser – a handheld UVB laser used in doctors’ offices to zap diseased skin with high-intensity, targeted light. XTRAC is FDA-cleared for conditions like
14 October 2025
 ·  ·  ·  ·  · 
Digital Health & Telemedicine Industry Update (June–July 2025)

Digital Health & Telemedicine Industry Update (June–July 2025)

In early June 2025, DispatchHealth and Medically Home completed a merger, forming one of the nation’s largest high-acuity hospital-at-home providers and operating under the DispatchHealth brand, integrating Medically Home’s virtual care technology and 24/7 clinical command centers. Teladoc Health signaled a growth and acquisitions pivot under CEO Chuck Divita, after two 2025 deals—Catapult Health (February) and UpLift (May)—to bolster chronic care management and insurance-billed virtual therapy. Novo Nordisk terminated its Wegovy distribution deal with Hims & Hers Health in late June 2025 over concerns about unregulated compounded semaglutide, sending Hims & Hers’ stock down about 30%. HerMD launched Virtual Care
3 July 2025
 ·  ·  ·  ·  ·  ·  ·  · 
Go toTop